GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (AMEX:STXS) » Definitions » Shiller PE Ratio

Stereotaxis (Stereotaxis) Shiller PE Ratio : (As of Jun. 03, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Stereotaxis Shiller PE Ratio Historical Data

The historical data trend for Stereotaxis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis Shiller PE Ratio Chart

Stereotaxis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Stereotaxis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stereotaxis's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Stereotaxis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Shiller PE Ratio falls into.



Stereotaxis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Stereotaxis's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Stereotaxis's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.06/131.7762*131.7762
=-0.060

Current CPI (Mar. 2024) = 131.7762.

Stereotaxis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.100 100.560 -0.131
201409 0.001 100.428 0.001
201412 0.040 99.070 0.053
201503 -0.150 99.621 -0.198
201506 -0.070 100.684 -0.092
201509 -0.050 100.392 -0.066
201512 -0.080 99.792 -0.106
201603 -0.110 100.470 -0.144
201606 -0.110 101.688 -0.143
201609 -0.560 101.861 -0.724
201612 0.240 101.863 0.310
201703 0.010 102.862 0.013
201706 -0.020 103.349 -0.026
201709 -0.210 104.136 -0.266
201712 -0.130 104.011 -0.165
201803 0.010 105.290 0.013
201806 -0.020 106.317 -0.025
201809 -0.010 106.507 -0.012
201812 -0.020 105.998 -0.025
201903 -0.040 107.251 -0.049
201906 -0.030 108.070 -0.037
201909 -0.005 108.329 -0.006
201912 -0.020 108.420 -0.024
202003 -0.030 108.902 -0.036
202006 -0.030 108.767 -0.036
202009 -0.030 109.815 -0.036
202012 -0.020 109.897 -0.024
202103 -0.020 111.754 -0.024
202106 -0.020 114.631 -0.023
202109 -0.070 115.734 -0.080
202112 -0.050 117.630 -0.056
202203 -0.060 121.301 -0.065
202206 -0.070 125.017 -0.074
202209 -0.070 125.227 -0.074
202212 -0.060 125.222 -0.063
202303 -0.070 127.348 -0.072
202306 -0.070 128.729 -0.072
202309 -0.070 129.860 -0.071
202312 -0.060 129.419 -0.061
202403 -0.060 131.776 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stereotaxis  (AMEX:STXS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Stereotaxis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Stereotaxis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stereotaxis (Stereotaxis) Business Description

Traded in Other Exchanges
Address
710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Executives
Paul J Isaac 10 percent owner 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Myriam Curet director 1020 KIFER ROAD, SUNNYVALE CA 94086
David Benfer director 5 SELDEN AVENUE, BRANFORD CT 06404
Kimberly R. Peery officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE: SUITE 100, ST. LOUIS MO 63108
Kevin M. Barry officer: Chief Legal Officer & Secretar 4320 FOREST PARK AVENUE, 100, ST. LOUIS MO 63108
Ross B Levin director 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Fariba Fischel Ghodsian 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Dafna Capital Management Llc 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
David Leo Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Arun Swarup Menawat director 2412 EIGHTH LINE, OAKVILLE A6 L6H6S9
Joe E Kiani director 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Brathwaite officer: VP Research & Development C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Martin C Stammer officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Nathan Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Duane Desisto director C/O INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730